Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Y.J.L. Bodar"'
Autor:
Y.J.L. Bodar, B.P.F. Koene, D. Meijer, P.J. Van Leeuwen, J.A. Nieuwenhuijzen, R.J.A. Van Moorselaar, N.H. Hendrikse, D.E. Oprea-Lager, A.N. Vis
Publikováno v:
European Urology Open Science, Vol 21, Iss , Pp S66- (2020)
Externí odkaz:
https://doaj.org/article/4da9e082b8104279895123ced9bb37b7
Autor:
D. Meijer, M.L. Donswijk, Y.J.L. Bodar, P.J. Van Leeuwen, H.G. Van Der Poel, W.V. Vogel, J.A. Nieuwenhuijzen, N.H. Hendrikse, D.E. Oprea-Lager, A.N. Vis
Publikováno v:
European Urology Open Science, Vol 21, Iss , Pp S61-S62 (2020)
Externí odkaz:
https://doaj.org/article/3801a2b5d0cf477fa50005d6b30ef46b
Autor:
Y.J.L. Bodar, B.P.F. Koene, B.H.E. Jansen, M.C.F. Cysouw, D. Meijer, N.H. Hendrikse, A.N. Vis, R. Boellaard, D.E. Oprea-Lager
Publikováno v:
European Urology Open Science, Vol 21, Iss , Pp S69-S70 (2020)
Externí odkaz:
https://doaj.org/article/b453661b83144b099cccf66b71451c9b
Autor:
D. Meijer, H. De Barros, Y.J.L. Bodar, P.J. Van Leeuwen, B.H.E. Jansen, T.M. Van Der Sluis, H.G. Van Der Poel, J.A. Nieuwenhuijzen, D.E. Oprea-Lager, A.N. Vis
Publikováno v:
European Urology Open Science, Vol 21, Iss , Pp S87- (2020)
Externí odkaz:
https://doaj.org/article/da02f76a71f945e5be9f066fc75e9fe2
Autor:
Y.J.L. Bodar, B.H.E. Jansen, P.J. Van Der Voorn, G.J.C. Zwezerijnen, J.A. Nieuwenhuijzen, N.H. Hendrikse, R.J.A. Van Moorselaar, D.E. Oprea-Lager, A.N. Vis
Publikováno v:
European Urology Open Science, Vol 19, Iss , Pp e470-e471 (2020)
Externí odkaz:
https://doaj.org/article/62b6053ece9f42e5a8dd45bfafaeaae7
Autor:
B.H.E. Jansen, Y.J.L. Bodar, G.J.C. Zwezerijnen, J.A. Nieuwenhuijzen, M. Wondergem, T. Roeleveld, O.S. Hoektra, J. Van Moorselaar, D.E. Oprea-Lager, A.N. Vis
Publikováno v:
European Urology Open Science, Vol 19, Iss , Pp e1699- (2020)
Externí odkaz:
https://doaj.org/article/e24d908f3fbd4bfe846b1085e3e37b7b
Autor:
Y.J.L. Bodar, W.I. Luining, B. Keizer, D. Meijer, A. Vellekoop, M. Schaaf, N.H. Hendrikse, R.J.A. Van Moorselaar, D.E. Oprea-Lager, A.N. Vis
Publikováno v:
Bodar, Y J L, Luining, W I, Keizer, B, Meijer, D, Vellekoop, A, Schaaf, M, Hendrikse, N H, van Moorselaar, R J A, Oprea-Lager, D E & Vis, A N 2023, ' A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and 18F-PSMA-PET/CT ', Urologic Oncology: Seminars and Original Investigations, vol. 41, no. 4, pp. 205.e17-205.e24 . https://doi.org/10.1016/j.urolonc.2022.12.006
Urologic Oncology: Seminars and Original Investigations, 41(4), 205.e17-205.e24. Elsevier Inc.
Urologic Oncology: Seminars and Original Investigations, 41(4), 205.e17-205.e24. Elsevier Inc.
Purpose: Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is an emerging staging tool for patients with primary high-risk prostate cancer (PCa). Patients with primary metastatic disease are staged us
Autor:
K. De Bie, André N. Vis, D. Meijer, B.H.E. Jansen, A.D. Windhorst, Y.J.L. Bodar, D.E. Oprea-Lager, S.Q. Kol, N.H. Hendrikse, G.J.C. Zwezerijnen, M. Yaqub, R.S. Smit, J.P. Van Der Voorn
Publikováno v:
European Urology Open Science. 33:S220-S222
Autor:
Otto S. Hoekstra, G.J.C. Zwezerijnen, J.P. Van Der Voorn, Jakko A. Nieuwenhuijzen, N.H. Hendrikse, Daniela E. Oprea-Lager, B.H.E. Jansen, André N. Vis, D. Meijer, Y.J.L. Bodar, R.J.A. van Moorselaar, Ronald Boellaard
Publikováno v:
Bodar, Y J L, Jansen, B H E, van der Voorn, J P, Zwezerijnen, G J C, Meijer, D, Nieuwenhuijzen, J A, Boellaard, R, Hendrikse, N H, Hoekstra, O S, van Moorselaar, R J A, Oprea-Lager, D E & Vis, A N 2021, ' Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens : is PSMA-targeted biopsy feasible? The DeTeCT trial ', World Journal of Urology, vol. 39, no. 7, pp. 2439–2446 . https://doi.org/10.1007/s00345-020-03490-8
World Journal of Urology, 39(7), 2439-2446. Springer Verlag
World Journal of Urology, 39(7). Springer Verlag
World Journal of Urology
World Journal of Urology, 39(7), 2439-2446. Springer Verlag
World Journal of Urology, 39(7). Springer Verlag
World Journal of Urology
Purpose In primary prostate cancer (PCa) patients, accurate staging and histologic grading are crucial to guide treatment decisions. 18F-DCFPyL (PSMA)-PET/CT has been successfully introduced for (re)staging PCa, showing high accuracy to localise PCa
Autor:
Y.J.L. Bodar, André N. Vis, Ronald Boellaard, B.H.E. Jansen, Berend Pieter Francis Koene, Matthijs C.F. Cysouw, Harry Hendrikse, Daniela E. Oprea-Lager, D. Meijer
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 62(9), 1264-1269
Bodar, Y J L, Koene, B P F, Jansen, B H E, Cysouw, M C F, Meijer, D, Hendrikse, N H, Vis, A N, Boellaard, R & Oprea-Lager, D E 2021, ' SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden ', Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol. 62, no. 9, pp. 1264-1269 . https://doi.org/10.2967/jnumed.120.260232, https://doi.org/10.2967/jnumed.120.260232
Bodar, Y J L, Koene, B P F, Jansen, B H E, Cysouw, M C F, Meijer, D, Hendrikse, N H, Vis, A N, Boellaard, R & Oprea-Lager, D E 2021, ' SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden ', Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol. 62, no. 9, pp. 1264-1269 . https://doi.org/10.2967/jnumed.120.260232, https://doi.org/10.2967/jnumed.120.260232
In prostate cancer (PCa) patients, the tumor-to-blood ratio (TBR) has been validated as the preferred simplified method for lesional 18F-DCFPyL (a radiolabeled prostate-specific membrane antigen ligand) uptake quantification on PET. In contrast to SU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c04e0a2e8e1c8918a6a16bc556ce360b
https://research.vumc.nl/en/publications/e03b33aa-c948-412e-b9bb-26fe93f025fc
https://research.vumc.nl/en/publications/e03b33aa-c948-412e-b9bb-26fe93f025fc